BIOVENTUS INC - A (BVS) Fundamental Analysis & Valuation

NASDAQ:BVS • US09075A1088

Current stock price

8.62 USD
+0.02 (+0.23%)
At close:
8.62 USD
0 (0%)
After Hours:

This BVS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. BVS Profitability Analysis

1.1 Basic Checks

  • In the past year BVS was profitable.
  • BVS had a positive operating cash flow in the past year.
  • In multiple years BVS reported negative net income over the last 5 years.
  • Of the past 5 years BVS 4 years had a positive operating cash flow.
BVS Yearly Net Income VS EBIT VS OCF VS FCFBVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

1.2 Ratios

  • BVS has a better Return On Assets (3.33%) than 78.80% of its industry peers.
  • Looking at the Return On Equity, with a value of 12.35%, BVS belongs to the top of the industry, outperforming 86.96% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 8.50%, BVS belongs to the top of the industry, outperforming 84.24% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for BVS is significantly below the industry average of 9.18%.
  • The 3 year average ROIC (3.98%) for BVS is below the current ROIC(8.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.33%
ROE 12.35%
ROIC 8.5%
ROA(3y)-6.97%
ROA(5y)-6.18%
ROE(3y)-34.02%
ROE(5y)-29.59%
ROIC(3y)3.98%
ROIC(5y)N/A
BVS Yearly ROA, ROE, ROICBVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • BVS's Profit Margin of 4.00% is fine compared to the rest of the industry. BVS outperforms 75.00% of its industry peers.
  • BVS's Profit Margin has improved in the last couple of years.
  • BVS's Operating Margin of 9.91% is fine compared to the rest of the industry. BVS outperforms 77.72% of its industry peers.
  • BVS's Operating Margin has improved in the last couple of years.
  • BVS's Gross Margin of 68.33% is fine compared to the rest of the industry. BVS outperforms 75.54% of its industry peers.
  • In the last couple of years the Gross Margin of BVS has remained more or less at the same level.
Industry RankSector Rank
OM 9.91%
PM (TTM) 4%
GM 68.33%
OM growth 3YN/A
OM growth 5Y3.04%
PM growth 3YN/A
PM growth 5Y23.91%
GM growth 3Y1.86%
GM growth 5Y-1.23%
BVS Yearly Profit, Operating, Gross MarginsBVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BVS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BVS is destroying value.
  • The number of shares outstanding for BVS has been reduced compared to 1 year ago.
  • The number of shares outstanding for BVS has been increased compared to 5 years ago.
  • Compared to 1 year ago, BVS has an improved debt to assets ratio.
BVS Yearly Shares OutstandingBVS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
BVS Yearly Total Debt VS Total AssetsBVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 1.47, we must say that BVS is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.47, BVS perfoms like the industry average, outperforming 52.72% of the companies in the same industry.
  • The Debt to FCF ratio of BVS is 4.21, which is a neutral value as it means it would take BVS, 4.21 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 4.21, BVS is doing good in the industry, outperforming 78.80% of the companies in the same industry.
  • A Debt/Equity ratio of 1.56 is on the high side and indicates that BVS has dependencies on debt financing.
  • BVS has a worse Debt to Equity ratio (1.56) than 79.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 4.21
Altman-Z 1.47
ROIC/WACC0.82
WACC10.39%
BVS Yearly LT Debt VS Equity VS FCFBVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • BVS has a Current Ratio of 1.70. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
  • BVS's Current ratio of 1.70 is on the low side compared to the rest of the industry. BVS is outperformed by 70.11% of its industry peers.
  • A Quick Ratio of 1.19 indicates that BVS should not have too much problems paying its short term obligations.
  • The Quick ratio of BVS (1.19) is worse than 69.02% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.19
BVS Yearly Current Assets VS Current LiabilitesBVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BVS Growth Analysis

3.1 Past

  • BVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.68%, which is quite impressive.
  • Measured over the past years, BVS shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.76% on average per year.
  • The Revenue has decreased by -0.91% in the past year.
  • The Revenue has been growing by 12.08% on average over the past years. This is quite good.
EPS 1Y (TTM)44.68%
EPS 3Y61.98%
EPS 5Y32.76%
EPS Q2Q%60%
Revenue 1Y (TTM)-0.91%
Revenue growth 3Y3.52%
Revenue growth 5Y12.08%
Sales Q2Q%2.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.25% on average over the next years. This is quite good.
  • Based on estimates for the next years, BVS will show a small growth in Revenue. The Revenue will grow by 6.77% on average per year.
EPS Next Y14.86%
EPS Next 2Y14.11%
EPS Next 3YN/A
EPS Next 5Y12.25%
Revenue Next Year6.78%
Revenue Next 2Y6.62%
Revenue Next 3YN/A
Revenue Next 5Y6.77%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BVS Yearly Revenue VS EstimatesBVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 200M 400M 600M
BVS Yearly EPS VS EstimatesBVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 0 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

8

4. BVS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 12.68, which indicates a correct valuation of BVS.
  • Based on the Price/Earnings ratio, BVS is valued cheaply inside the industry as 89.13% of the companies are valued more expensively.
  • BVS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.70.
  • A Price/Forward Earnings ratio of 11.04 indicates a reasonable valuation of BVS.
  • Based on the Price/Forward Earnings ratio, BVS is valued cheaper than 92.93% of the companies in the same industry.
  • BVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 12.68
Fwd PE 11.04
BVS Price Earnings VS Forward Price EarningsBVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 92.93% of the companies listed in the same industry.
  • BVS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BVS is cheaper than 98.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.89
EV/EBITDA 9.33
BVS Per share dataBVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BVS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as BVS's earnings are expected to grow with 14.11% in the coming years.
PEG (NY)0.85
PEG (5Y)0.39
EPS Next 2Y14.11%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BVS Dividend Analysis

5.1 Amount

  • BVS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BVS Fundamentals: All Metrics, Ratios and Statistics

BIOVENTUS INC - A

NASDAQ:BVS (3/13/2026, 8:12:57 PM)

After market: 8.62 0 (0%)

8.62

+0.02 (+0.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-05
Earnings (Next)05-04
Inst Owners77.64%
Inst Owner Change2.28%
Ins Owners2.61%
Ins Owner Change0.55%
Market Cap713.39M
Revenue(TTM)568.09M
Net Income(TTM)22.73M
Analysts82.5
Price Target14.79 (71.58%)
Short Float %2.63%
Short Ratio6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.41%
Min EPS beat(2)9.67%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)69.33%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)103.52%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.15%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.96%
Revenue beat(4)2
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)0.96%
Revenue beat(8)6
Avg Revenue beat(8)3.18%
Revenue beat(12)10
Avg Revenue beat(12)3.35%
Revenue beat(16)11
Avg Revenue beat(16)1.45%
PT rev (1m)-3.33%
PT rev (3m)-3.33%
EPS NQ rev (1m)0.78%
EPS NQ rev (3m)0.78%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 12.68
Fwd PE 11.04
P/S 1.26
P/FCF 9.89
P/OCF 9.55
P/B 3.87
P/tB N/A
EV/EBITDA 9.33
EPS(TTM)0.68
EY7.89%
EPS(NY)0.78
Fwd EY9.06%
FCF(TTM)0.87
FCFY10.11%
OCF(TTM)0.9
OCFY10.47%
SpS6.86
BVpS2.22
TBVpS-2.32
PEG (NY)0.85
PEG (5Y)0.39
Graham Number5.83
Profitability
Industry RankSector Rank
ROA 3.33%
ROE 12.35%
ROCE 10.76%
ROIC 8.5%
ROICexc 9.42%
ROICexgc 46.29%
OM 9.91%
PM (TTM) 4%
GM 68.33%
FCFM 12.69%
ROA(3y)-6.97%
ROA(5y)-6.18%
ROE(3y)-34.02%
ROE(5y)-29.59%
ROIC(3y)3.98%
ROIC(5y)N/A
ROICexc(3y)4.38%
ROICexc(5y)N/A
ROICexgc(3y)24.58%
ROICexgc(5y)N/A
ROCE(3y)5.03%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.39%
ROICexc growth 3YN/A
ROICexc growth 5Y4.41%
OM growth 3YN/A
OM growth 5Y3.04%
PM growth 3YN/A
PM growth 5Y23.91%
GM growth 3Y1.86%
GM growth 5Y-1.23%
F-Score8
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 4.21
Debt/EBITDA 2.78
Cap/Depr 5.45%
Cap/Sales 0.45%
Interest Coverage 2.08
Cash Conversion 72.29%
Profit Quality 317.22%
Current Ratio 1.7
Quick Ratio 1.19
Altman-Z 1.47
F-Score8
WACC10.39%
ROIC/WACC0.82
Cap/Depr(3y)6.77%
Cap/Depr(5y)11.29%
Cap/Sales(3y)0.69%
Cap/Sales(5y)1.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.68%
EPS 3Y61.98%
EPS 5Y32.76%
EPS Q2Q%60%
EPS Next Y14.86%
EPS Next 2Y14.11%
EPS Next 3YN/A
EPS Next 5Y12.25%
Revenue 1Y (TTM)-0.91%
Revenue growth 3Y3.52%
Revenue growth 5Y12.08%
Sales Q2Q%2.77%
Revenue Next Year6.78%
Revenue Next 2Y6.62%
Revenue Next 3YN/A
Revenue Next 5Y6.77%
EBIT growth 1Y128.66%
EBIT growth 3YN/A
EBIT growth 5Y15.49%
EBIT Next Year49.52%
EBIT Next 3YN/A
EBIT Next 5Y17.26%
FCF growth 1Y90.83%
FCF growth 3YN/A
FCF growth 5Y1.27%
OCF growth 1Y92.48%
OCF growth 3YN/A
OCF growth 5Y0.79%

BIOVENTUS INC - A / BVS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?

ChartMill assigns a fundamental rating of 5 / 10 to BVS.


What is the valuation status for BVS stock?

ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.


Can you provide the profitability details for BIOVENTUS INC - A?

BIOVENTUS INC - A (BVS) has a profitability rating of 7 / 10.


What is the valuation of BIOVENTUS INC - A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BIOVENTUS INC - A (BVS) is 12.68 and the Price/Book (PB) ratio is 3.87.


What is the financial health of BIOVENTUS INC - A (BVS) stock?

The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.